文献类型：期刊文献

英文题名：The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and psychometric validation study

作者：Paterson, Amy[1];Mughogho, Kondwani K.[2];Cheyne, Ashleigh[1];Kabajaasi, Olive[3];Sarkar, Tonmoy[4];Dimitrios, Kkunsa Hadson[5];Tulunay, Harun[6];Adiukwu, Frances N.[7];Alatrany, Saad S.[8,9];Mamaghani, Ebrahim Aliafsari[10];Barberia, Lorena G.[11];Bu, He[12];Chikura-Dlamini, Precious[13];Dunning, Jake[1];Gregorio Jr, Ernesto R.[14];Hassan, Md Zakiul[1,4];Hossain, Mohammad B.[15];Jamrozik, Euzebiusz[1,16,17,18,19];Mistry, Sabuj Kanti[20];Mwima, Gerald A.[21];Nochaiwong, Surapon[22];Nutland, Will[23];Orkin, Chloe[24];Rahman, Dewan, I[4];Roelen, Keetie[25];Ryu, Soomin[26];Schilling, Stefan[27];Sentongo, Hafsa L.[28];Sekikongo, Musoke T.[29];Stangl, Anne L.[30];Ssewankambo, Yasin[31];Sukmaningrum, Evi[32];Tan, Rayner K. J.[33,34];Taylor, Steven[35];Torres, Thiago S.[36];Tomczyk, Samuel[37,38];Wang, Xiaomin[39];Jones, Benjamin[40,41];Chowdhury, Kamal I. A.[4];Khan, Md Sharful, I;Aquib, Wasik R.[4];Satter, Syed M.[4];Kenya-Mugisha, Nathan[3];Stolow, Jeni[42];Gobat, Nina[43];Olliaro, Piero[1];Rojek, Amanda[1]

机构：[1]Univ Oxford, Pandem Sci Inst, Oxford OX3 7DQ, England;[2]Univ Cambridge, Psychometr Ctr, Judge Business Sch, Cambridge, England;[3]World Alliance Lung & Intens Care Med Uganda, Social Sci Dept, Kampala, Uganda;[4]Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Dhaka, Bangladesh;[5]St Nikolas Pharm, Kampala, Uganda;[6]Positively UK, London, England;[7]Univ Port Harcourt, Dept Mental Hlth, Choba, Nigeria;[8]Imam Jaafar Al Sadiq Univ, Dept Clin Psychol, Baghdad, Iraq;[9]Univ Baghdad, Coll Educ Human Sci Ibn Reshed, Baghdad, Iraq;[10]Maragheh Univ Med Sci, Maragheh, Iran;[11]Univ Sao Paulo, Dept Polit Sci, Sao Paulo, Brazil;[12]East China Univ Sci & Technol, Social & Publ Adm Sch, Shanghai, Peoples R China;[13]Univ Oxford, Nuffield Dept Med, Oxford, England;[14]Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines;[15]Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh;[16]Univ Melbourne, Dept Infect Dis, Melbourne, Vic, Australia;[17]Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic, Australia;[18]Univ Oxford, Ethox Ctr, Oxford, England;[19]Monash Univ, Monash Bioeth Ctr, Melbourne, Vic, Australia;[20]Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia;[21]Baylor Coll Med, Kampala, Uganda;[22]Chiang Mai Univ, Fac Pharm, Pharmacoepidemiol & Stat Res Ctr, Chiang Mai, Thailand;[23]Love Tank, London, England;[24]Queen Mary Univ London, Blizard Inst, SHARE Collaborat, London, England;[25]Open Univ, Fac Wellbeing Educ & Language Studies, Ctr Study Global Dev, Milton Keynes, England;[26]Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI USA;[27]Univ Exeter, Fac Hlth & Life Sci, Exeter, England;[28]Minist Hlth Uganda, Mental Hlth & Control Subst Use, Kampala, Uganda;[29]Mulago Natl Specialised Hosp, Internal Med, Kampala, Uganda;[30]Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA;[31]Entebbe Isolat Ctr, Entebbe, Uganda;[32]Atma Jaya Catholic Univ Indonesia, Fac Psychol, Jakarta, Indonesia;[33]Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore;[34]Natl Univ Hlth Syst, Singapore, Singapore;[35]Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada;[36]Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil;[37]Univ Greifswald, Inst Psychol, Dept Hlth & Prevent, Greifswald, Germany;[38]German Ctr Child & Adolescent Hlth, Greifswald, Germany;[39]Hangzhou Normal Univ, Sch Publ Hlth, Hangzhou, Peoples R China;[40]Univ Oxford, Hlth Syst Collaborat, Oxford, England;[41]Menzies Sch Hlth Res, Darwin, NT, Australia;[42]Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA;[43]Univ Oxford, Nuffield Dept Primary Care Hlth Serv, Oxford, England

年份：2025

卷号：25

期号：11

起止页码：e635

外文期刊名：LANCET INFECTIOUS DISEASES

收录：;WOS:【SCI-EXPANDED(收录号:WOS:001607166300001)】；

基金：funding from US Centers for Disease Control and Prevention (CDC) . STo has received funding from The Federal Ministry of Education and Research, Germany, for a separate stigma-related research project. WRA has received grants from US CDC and support for travel from CEPI. KIAC and SMS have received institutional funding through an agreement with US CDC. AP is funded by a Rhodes Scholarship. All other authors declare no competing interests.r funding from US Centers for Disease Control and Prevention (CDC) . STo has received funding from The Federal Ministry of Education and Research, Germany, for a separate stigma-related research project. WRA has received grants from US CDC and support for travel from CEPI. KIAC and SMS have received institutional funding through an agreement with US CDC. AP is funded by a Rhodes Scholarship. All other authors declare no competing interests.

语种：英文

摘要：Reducing stigma during infectious disease outbreaks is crucial for delivering an effective response. However, no validated stigma scales exist for use across outbreaks, and outbreak-specific scales are developed too slowly to guide timely interventions. To enable more real-time monitoring and mitigation of stigma across outbreak contexts, we developed and validated the (Re)-emerging and ePidemic Infectious Diseases (RAPID) Stigma Scales. Field testing and psychometric validation were conducted in communities affected by Ebola disease in Uganda, mpox in the UK, and Nipah virus disease in Bangladesh. Content validity was established through cognitive interviews and expert Delphi scoring. 1008 respondents were included across the three countries. The final RAPID Community Stigma Scale (12 items) captures initial social stigma, provider or authority-related stigma, structural stigma, and enduring social stigma. The RAPID Self Stigma Scale (4 items) is unidimensional. Both scales were found to have robust psychometric properties, including content validity, structural validity (factor loadings >= 06), and reliability (ordinal alphas 079-092). High scores on both scales predicted an increased hesitancy to report symptoms and seek care. The RAPID Stigma Scales are validated tools for real-time assessment of stigma across outbreak settings, enabling responders to design targeted interventions to improve health outcomes and promote equitable care.